MIRA INFORM REPORT

Report Date :

14.04.2012

IDENTIFICATION DETAILS

Name :	MAKNSONS

Registered Office :	310, Portway Trade Centre, S.M.C.H.S., Shahrah-e-Faisal, Karachi

Country :	Pakistan

Year of Establishment :	2011

Legal Form :	Partnership

Line of Business :	Emerging health care company which deals in clinically proven European premium probiotics of human origin, most commonly used for children

No. of Employees :	6

RATING & COMMENTS

MIRA’s Rating :

RATING

STATUS

PROPOSED CREDIT LINE

New Business

Status :	New Company
Payment Behaviour :	Unknown
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – March 31^st, 2012

Country Name

Previous Rating

(31.12.2011)

Current Rating

(31.03.2012)

Pakistan

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

Business Name

MAKNSONS

Full Address

Registered Address

310, Portway Trade Centre, S.M.C.H.S., Shahrah-e-Faisal, Karachi, Pakistan

Tel #	92 (21) 34329092
Fax #	92 (21) 34329092

Short Description Of Business

a.	Nature of Business	Emerging health care company which deals in clinically proven European premium probiotics of human origin, most commonly used for children
b.	Year Established	2011

Branches

None

Legal Status

Subject Company was established as a Partnership business in 2011

Details of Management

Names

Nationality

Address

Occupation

Designation

Mr. S. Makhmoor

Mrs. Sabah Makhmoor

Pakistani

310, Portway Trade Centre, S.M.C.H.S., Shahrah-e-Faisal, Karachi

Business

President

Vice President

Associated Companies

None

Business Activities

Subject is an emerging health care company which deals in clinically proven European premium probiotics of human origin, most commonly used for children.

It’s mainly import from European Countries, Canada, U.S.A. & U.K.

Its’ major customers are Pharmaceutical Manufacturers, Distribution Companies etc.

Subject operates from caption leased office premises of area measuring 650 Sq.ft. which is situated at main commercial area of Karachi.

Subject employs about 6 persons in its set up.

Annual Sales Volume

Year	In Pak Rupees
2011	Not ascertained as the subject is a new Company

Trade Suppliers (Foreign)

Subject mainly import from Companies belongs to Europe, Canada, U.S.A. & U.K.

Bankers

(1) Citibank N.A., Pakistan.

(2) Faysal Bank Limited, Pakistan.

(3) Bank Alfalah Limited, Pakistan.

Foreign Exchange Rates

Currency	Unit	Pakistani Rupee
US Dollar	1	Rs. 91.10
UK Pound	1	Rs. 144.50
Euro	1	Rs. 119.30

Comments

Subject Company was established in 2011. Subject is an emerging health care Company which deals in clinically proven European premium probiotics of human origin, most commonly used for children. Trade relations are reported as fair. Subject can be considered for normal business dealings at usual trade terms and conditions.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.51.42
UK Pound	1	Rs.81.93
Euro	1	Rs.67.67

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
--	NB	New Business	--

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.